Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy

Author： Gentile Giovanna Borro Marina Simmaco Maurizio Missori Serena Lala Noemi Martelletti Paolo

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.1, 2011-01, pp. : 39-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triptans in Migraine: A Comparative Review of Pharmacology, Pharmacokinetics and Efficacy

By Tfelt-Hansen P.

Drugs, Vol. 60, Iss. 6, 2000-12 ,pp. : 1259-1287

Adis International

Access to resources Recommend Favorite

Influence of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Sulfonylurea Drugs

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 643-658

Bentham Science Publishers

Access to resources Recommend Favorite

Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine

By Tfelt-Hansen Peer Hougaard Anders

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 91-103

Informa Healthcare

Access to resources Recommend Favorite

Triptans for the Management of Migraine

By Johnston Mollie M. Rapoport Alan M.

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1505-1518

Adis International

Access to resources Recommend Favorite

The Role of Unbound Drug in Pharmacokinetics/Pharmacodynamics and in Therapy

Current Pharmaceutical Design, Vol. 12, Iss. 8, 2006-03 ,pp. : 977-987

Bentham Science Publishers

Access to resources Recommend Favorite